Skip to content

Drug interactions

Hydroxychloroquine + Pasireotide

Severity: Moderate

Hydroxychloroquine and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong the QT interval, partly via bradycardia, and hydroxychloroquine adds to this effect. The combination raises the risk of ventricular arrhythmia.

What this interaction means in plain words

Hydroxychloroquine and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Hydroxychloroquine belongs to Musculoskeletal; Pasireotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive QT prolongation through pharmacodynamic effects.

What to do

Obtain a baseline ECG, correct hypokalemia and hypomagnesemia, and monitor QTc during co-therapy; consider alternatives in patients with baseline QT prolongation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydroxychloroquine and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Hydroxychloroquine with Pasireotide?

MediHelp rates the interaction as moderate. Hydroxychloroquine and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can prolong the QT interval, partly via bradycardia, and hydroxychloroquine adds to this effect. The combination raises the risk of ventricular arrhythmia.

How serious is the interaction between Hydroxychloroquine and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG, correct hypokalemia and hypomagnesemia, and monitor QTc during co-therapy; consider alternatives in patients with baseline QT prolongation.

What other medicines interact with Hydroxychloroquine?

MediHelp also lists interactions of Hydroxychloroquine with, for example, Arsenic trioxide, Cisapride, Dronedarone. The full list is on the Hydroxychloroquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in